Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.

Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol. 2012 Mar 10; 30(8):830-6.

View in: PubMed

subject areas

Adult
Aged
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Doxorubicin
Etoposide
Female
Flow Cytometry
Hematopoietic Stem Cell Transplantation
Humans
Interleukin-15
Interleukin-7
Lymphocyte Depletion
Lymphoma
Male
Middle Aged
Prednisone
Rituximab
Salvage Therapy
Treatment Outcome
Vidarabine
Vincristine

authors with profiles

Michael R. Bishop